These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36059951)

  • 1. Impact of extracorporeal membrane oxygenation on voriconazole plasma concentrations: A retrospective study.
    Ye Q; Yu X; Chen W; Li M; Gu S; Huang L; Zhan Q; Wang C
    Front Pharmacol; 2022; 13():972585. PubMed ID: 36059951
    [No Abstract]   [Full Text] [Related]  

  • 2. A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation.
    Van Daele R; Bekkers B; Lindfors M; Broman LM; Schauwvlieghe A; Rijnders B; Hunfeld NGM; Juffermans NP; Taccone FS; Coimbra Sousa CA; Jacquet LM; Laterre PF; Nulens E; Grootaert V; Lyster H; Reed A; Patel B; Meersseman P; Debaveye Y; Wauters J; Vandenbriele C; Spriet I
    Microorganisms; 2021 Jul; 9(7):. PubMed ID: 34361978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study.
    Ronda M; Llop-Talaveron JM; Fuset M; Leiva E; Shaw E; Gumucio-Sanguino VD; Diez Y; Colom H; Rigo-Bonnin R; Puig-Asensio M; Carratalà J; Padullés A
    Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluctuating Voriconazole Concentrations during Extracorporeal Membrane Oxygenation.
    Vu T; Feih J; Juul J
    J Pharm Pract; 2023 Aug; 36(4):998-1001. PubMed ID: 35612553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voriconazole pharmacokinetics in a critically ill patient during extracorporeal membrane oxygenation.
    Lin XB; Hu XG; Xia YZ; Liu XM; Liang T; Chen X; Cai CJ
    J Chemother; 2022 Jul; 34(4):272-276. PubMed ID: 34904531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation.
    Spriet I; Annaert P; Meersseman P; Hermans G; Meersseman W; Verbesselt R; Willems L
    J Antimicrob Chemother; 2009 Apr; 63(4):767-70. PubMed ID: 19218271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing voriconazole requirement in a patient after extracorporeal membrane oxygenation discontinuation: A case report.
    Peterson EL; Chittick PJ; Richardson CL
    Transpl Infect Dis; 2021 Jun; 23(3):e13545. PubMed ID: 33316840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between voriconazole exposure and Sequential Organ Failure Assessment (SOFA) score in critically ill patients.
    Bienvenu AL; Pradat P; Plesa A; Leclerc V; Piriou V; Fellahi JL; Argaud L; Rimmelé T; Menotti J; Aubrun F; Richard JC; Gagnieu MC; Parant F; Chidiac C; Leboucher G; Tod M; Goutelle S
    PLoS One; 2021; 16(11):e0260656. PubMed ID: 34818379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
    Hahn J; Choi JH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
    Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Jakob SM; Levkovich BJ; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Roberts JA; Shekar K; Fraser JF
    Int J Antimicrob Agents; 2021 Dec; 58(6):106466. PubMed ID: 34688834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Vancomycin Dosing Guided by Therapeutic Drug Monitoring in Adult Patients Receiving Extracorporeal Membrane Oxygenation.
    Marella P; Roberts J; Hay K; Shekar K
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voriconazole therapeutic drug monitoring in critically ill patients improves efficacy and safety of antifungal therapy.
    Li H; Li M; Yan J; Gao L; Zhou L; Wang Y; Li Q; Wang J; Chen T; Wang T; Zheng J; Qiang W; Zhang Y; Shi Q
    Basic Clin Pharmacol Toxicol; 2020 Dec; 127(6):495-504. PubMed ID: 32639669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefepime pharmacokinetics in adult extracorporeal membrane oxygenation patients.
    Zheng L; Alshaer MH; Peloquin C; Venugopalan V; Alnuaimat HM; Converse M
    Pulm Pharmacol Ther; 2024 Mar; 84():102271. PubMed ID: 38008397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole Sequestration During Extracorporeal Membrane Oxygenation for Invasive Lung Aspergillosis: A Case Report.
    Mathieu A; Thiboutot Z; Ferreira V; Benoit P; Grandjean Lapierre S; HÉtu PO; Halwagi A
    ASAIO J; 2022 Mar; 68(3):e56-e58. PubMed ID: 33788798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing voriconazole plasma level in intensive care patients.
    Hinze CA; Fuge J; Grote-Koska D; Brand K; Slevogt H; Cornberg M; Simon S; Joean O; Welte T; Rademacher J
    JAC Antimicrob Resist; 2024 Apr; 6(2):dlae045. PubMed ID: 38500519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voriconazole therapeutic drug monitoring and hepatotoxicity in critically ill patients: A nationwide multi-centre retrospective study.
    Wang T; Miao L; Shao H; Wei X; Yan M; Zuo X; Zhang J; Hai X; Fan G; Wang W; Hu L; Zhou J; Zhao Y; Xie Y; Wang J; Guo S; Jin L; Li H; Liu H; Wang Q; Chen J; Li S; Dong Y
    Int J Antimicrob Agents; 2022; 60(5-6):106692. PubMed ID: 36372345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of extracorporeal membrane oxygenation (ECMO) support on piperacillin exposure in septic patients: a case-control study.
    Fillâtre P; Lemaitre F; Nesseler N; Schmidt M; Besset S; Launey Y; Maamar A; Daufresne P; Flecher E; Le Tulzo Y; Tadie JM; Tattevin P
    J Antimicrob Chemother; 2021 Apr; 76(5):1242-1249. PubMed ID: 33569597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.
    Shekar K; Fraser JF; Taccone FS; Welch S; Wallis SC; Mullany DV; Lipman J; Roberts JA;
    Crit Care; 2014 Dec; 18(6):565. PubMed ID: 25636084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
    Hahn J; Min KL; Kang S; Yang S; Park MS; Wi J; Chang MJ
    Microbiol Spectr; 2021 Dec; 9(3):e0063321. PubMed ID: 34937189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic therapeutic drug monitoring in intensive care patients treated with different modalities of extracorporeal membrane oxygenation (ECMO) and renal replacement therapy: a prospective, observational single-center study.
    Kühn D; Metz C; Seiler F; Wehrfritz H; Roth S; Alqudrah M; Becker A; Bracht H; Wagenpfeil S; Hoffmann M; Bals R; Hübner U; Geisel J; Lepper PM; Becker SL
    Crit Care; 2020 Nov; 24(1):664. PubMed ID: 33239110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.